Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial
Titel:
Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial
Auteur:
Nabholtz, Jean-Marc Cantin, Jacques Chang, Jose Guevin, Raymond Patel, Ravi Tkaczuk, Katherine Vodvarka, Pavel Lindsay, Mary-Ann Reese, David Riva, Alessandro Mackey, John